What type of study is this?

September 10, 2025

Precision medicine on a budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.

View Full Paper

Ask AI

Bookmark

Authors

AZAlexandra Lindsey Djomkam ZuneUniversity of Ghana COCharles Ochieng’ OlwalUniversity of Ghana EAEmmanuel AgbeliUniversity of Ghana

Discussion

Member takes

Implication

Computational analysis highlights adverse drug reactions in Black Africans, suggesting the need for tailored pharmacogenomic studies in precision medicine.

Key Points

Black Africans face a significant burden of adverse drug reactions from cancer drugs due to genetic variability and environmental factors.
Leveraging existing genetic data, the study reveals that commonly used cancer drugs may not be effective for Black Africans, increasing the risk of adverse drug reactions.
The approach outlines a low-cost methodology for evaluating drug safety and efficacy, emphasizing the importance of local pharmacogenomic studies.
Improving cancer treatment outcomes in Africa necessitates large-scale genomic studies to develop drugs specifically tailored for African populations.

Cite This Study

Zune et al. (2025) studied this question.

synapsesocial.com/papers/68c1885e9b7b07f3a06126e5 https://doi.org/10.3389/fbinf.2025.1555637

View Full Paper

Ask AI

Bookmark

Implication

Computational analysis highlights adverse drug reactions in Black Africans, suggesting the need for tailored pharmacogenomic studies in precision medicine.

Precision medicine on a budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.

Discussion

Member takes

Implication

Key Points

Cite This Study

Precision medicine on a budget in Africa: using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider